Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment.


BACKGROUND Anti-tumor necrosis factor-alpha and anti-integrin monoclonal antibodies show great benefits for inducing and maintaining remission, healing the mucosa and restoring the quality of life of patients with inflammatory bowel disease. However, the therapeutic potential of these intrinsically powerful biologicals is abated by a high variability in… (More)
DOI: 10.2174/1389450117666160307144329


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics